Literature DB >> 18352988

Can learning potential in schizophrenia be assessed with the standard CVLT-II? An exploratory study.

Anja Vaskinn1, Kjetil Sundet, Svein Friis, Torill Ueland, Carmen Simonsen, Astrid B Birkenaes, John A Engh, Stein Opjordsmoen, Ole A Andreassen.   

Abstract

This study examined the potential of using the regular administration of a common neuropsychological test, the CVLT-II, to assess learning potential in schizophrenia. Based on List A trial 1 performance and the learning slope, a schizophrenia sample was divided into three learning potential groups (non-learners, learners and high-achievers) that differed in the use of learning strategies. High-achievers utilized more semantic clustering than learners and non-learners, and non-learners were less consistent in words recalled than the other two groups. This standard administration approach is a promising, time-saving alternative to the modified tests of learning potential used so far.

Entities:  

Mesh:

Year:  2008        PMID: 18352988     DOI: 10.1111/j.1467-9450.2008.00627.x

Source DB:  PubMed          Journal:  Scand J Psychol        ISSN: 0036-5564


  3 in total

1.  Effect of aripiprazole on verbal memory and fluency in schizophrenic patients : results from the ESCAPE study.

Authors:  Chris Bervoets; Manuel Morrens; Kristof Vansteelandt; Frank Kok; Annick de Patoul; Veronique Halkin; Didier Pitsi; Eric Constant; Joseph Peuskens; Bernard Sabbe
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

2.  Data-driven methodology illustrating mechanisms underlying word list recall: applications to clinical research.

Authors:  Julia Longenecker; Philip Kohn; Stanley Liu; Brad Zoltick; Daniel R Weinberger; Brita Elvevåg
Journal:  Neuropsychology       Date:  2010-09       Impact factor: 3.295

3.  Working Memory Deficit as a Risk Factor for Severe Apathy in Schizophrenia: A 1-Year Longitudinal Study.

Authors:  Stéphane Raffard; Laure-Anne Gutierrez; Hanan Yazbek; Aurore Larue; Jean-Philippe Boulenger; Christophe Lançon; Michel Benoit; Catherine Faget; Joanna Norton; Delphine Capdevielle
Journal:  Schizophr Bull       Date:  2016-02-01       Impact factor: 9.306

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.